Company news
Shanghai Rightongene Biotechnology Co. Ltd. news in 2025
Shanghai Rightongene Biotechnology Co. Ltd.'s news releases, calls and decks from 2025, newest first.
Announcement on Using Self-owned Funds to Pay Funds Required for Investment Projects Financed by Raised Funds and Replacing Them with an Equal Amount of Raised Funds
November 14, 2025
Notice on Convening the 4th Extraordinary General Meeting in 2025
October 28, 2025
Announcement on Implementation of Semi-annual Dividend Distribution for 2025
October 16, 2025
Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
October 10, 2025
Announcement on Completing Industrial and Commercial Change Registration and Obtaining Renewed Business License
October 9, 2025
Announcement on Resolutions of the 5th Meeting of the 3rd Board of Supervisors
September 23, 2025
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
September 16, 2025
Announcement on Personnel Adjustments and Changes
September 8, 2025
Special Report on Semi-annual Deposit and Actual Use of Raised Funds in 2025
August 28, 2025
Announcement on Resolution of the 2024 Annual General Meeting
June 20, 2025
Announcement on Reply to Inquiry Letter for Information Disclosure Supervision of 2024 Annual Report
May 20, 2025
Announcement on Change of Sponsor Representative for Continuous Supervision
May 8, 2025
Report for Q1 2025
April 24, 2025
Announcement on Preliminary Earnings Estimate for 2024
February 27, 2025
Announcement on Obtaining Government Subsidy
February 24, 2025
Announcement on Implementation Results of Repurchasing Shares and Share Changes
February 19, 2025
Announcement on Progress in Repurchasing Shares through Call Auction
February 6, 2025
Announcement on Resolution of the 1st Meeting of the 2nd Board of Supervisors
January 27, 2025
Announcement on Provision and Reversal for Asset Impairment in the Second Half of 2024
January 17, 2025
Announcement on Adjusting Allowance for Independent Directors
January 10, 2025